NCT05736419 2026-04-08A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)Memorial Sloan Kettering Cancer CenterPhase 2 Recruiting24 enrolled